Credit Suisse Ag Aurinia Pharmaceuticals Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 219,468 shares of AUPH stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

219,468

Previous 219,468 -0.0%

Holding current value

$1.2 Million

Previous $1.97 Million 44.3%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$7.13 - $9.49 $396,406 - $527,615	55,597 Added 33.93%	219,468 $1.97 Million
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $31,709 - $50,073	4,081 Added 2.55%	163,871 $1.27 Million
Q2 2023 Aug 11, 2023	BUY	$8.96 - $11.69 $313,098 - $408,495	34,944 Added 27.99%	159,790 $1.55 Million
Q1 2023 May 10, 2023	BUY	$5.94 - $11.27 $50,965 - $96,696	8,580 Added 7.38%	124,846 $1.37 Million
Q4 2022 Feb 13, 2023	SELL	$4.11 - $8.14 $102,022 - $202,059	-24,823 Reduced 17.59%	116,266 $502,000

Q3 2022 Nov 10, 2022	BUY	$6.66 - $12.39 $308,544 - $574,003	46,328 Added 48.89%	141,089 $1.06 Million
Q2 2022 Aug 12, 2022	SELL	$8.95 - $12.8 $83,575 - $119,526	-9,338 Reduced 8.97%	94,761 $953,000
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $1.78 Million - $3.98 Million	-177,048 Reduced 62.97%	104,099 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $3.54 Million - $6.59 Million	199,200 Added 243.08%	281,147 $6.43 Million
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $175,186 - $377,459	-16,028 Reduced 16.36%	81,947 $1.81 Million
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $681,080 - $988,928	-68,108 Reduced 41.01%	97,975 $1.27 Million
Q1 2021 May 14, 2021	BUY	$12.3 - $18.73 $628,591 - $957,196	51,105 Added 44.45%	166,083 $2.16 Million
Q4 2020 Feb 12, 2021	BUY	$12.94 - $16.05 $231,522 - $287,166	17,892 Added 18.43%	114,978 $1.59 Million
Q3 2020 Nov 13, 2020	BUY	$13.19 - $16.66 $409,668 - $517,442	31,059 Added 47.04%	97,086 $1.43 Million
Q2 2020 Aug 12, 2020	SELL	$14.12 - $18.33 $57,397 - $74,511	-4,065 Reduced 5.8%	66,027 $1.07 Million
Q1 2020 May 13, 2020	BUY	$11.34 - $21.46 $235,123 - $444,951	20,734 Added 42.01%	70,092 $1.02 Million
Q4 2019 Feb 12, 2020	BUY	$3.88 - $21.42 $103,021 - $568,743	26,552 Added 116.43%	49,358 $1 Million
Q3 2019 Nov 12, 2019	SELL	$5.34 - $6.59 $7,993 - $9,865	-1,497 Reduced 6.16%	22,806 $121,000
Q2 2019 Aug 14, 2019	BUY	$6.05 - $6.75 $25,373 - $28,309	4,194 Added 20.86%	24,303 $160,000
Q1 2019 May 14, 2019	BUY	$6.06 - $7.64 $17,537 - $22,110	2,894 Added 16.81%	20,109 $130,000
Q4 2018 Feb 13, 2019	SELL	$5.08 - $6.83 $9,204 - $12,375	-1,812 Reduced 9.52%	17,215 $118,000
Q3 2018 Nov 13, 2018	SELL	$5.27 - $6.64 $20,294 - $25,570	-3,851 Reduced 16.83%	19,027 $127,000
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.36 $27,435 - $34,483	-5,422 Reduced 19.16%	22,878 $128,000
Q1 2018 May 15, 2018	BUY	$4.85 - $5.99 $43,751 - $54,035	9,021 Added 46.79%	28,300 $147,000
Q4 2017 Feb 14, 2018	BUY	$4.53 - $7.09 $87,333 - $136,688	19,279	19,279 $87,000

Others Institutions Holding AUPH

# of Institutions

205

Shares Held

55.6M

Call Options Held

838K

Put Options Held

1.18M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $776M
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account